Pharmaceuticals, Biotechnology and Life Sciences
— Phase II Grant to Advance Development of Live Biotherapeutic Product Candidate for Netherton Syndrome — FARMINGTON, Conn.–(BUSINESS WIRE)–Azitra, Inc.…
– Topline results anticipated in first half of 2020 – DALLAS–(BUSINESS WIRE)–Peloton Therapeutics, Inc., a clinical-stage biopharmaceutical company advancing first-in-class…
NIH Grant Fuels Development of Once-Weekly Oral Buprenorphine WATERTOWN, Mass.–(BUSINESS WIRE)–Lyndra Therapeutics, the company making daily pills a thing of…
Alignment with FDA on a single, pivotal, 12-week, placebo-controlled, Phase 3 clinical trial to initiate in the second half of…
Primary safety endpoint met as FX-322 was well tolerated Preliminary clinical data suggests improvement on measures of hearing function Company…
NanOlogy may offer an alternative treatment option for patients with bladder cancer Investigational drug, NanoDoce, is injected locally into tumor…
—Independent Data Safety Monitoring Board (DSMB) recommends HERACLES trial to continue without modification— —Patient recruitment in the study continues with…
BALLERUP, Denmark–(BUSINESS WIRE)–LEO Pharma A/S, a global leader in medical dermatology and Elektrofi, a Boston- based biotechnology company focused on…
— Experienced R&D strategist brings deep expertise in advanced breeding and gene editing technologies — DAVIS, Calif.–(BUSINESS WIRE)–Arcadia Biosciences, Inc.…
Pixantrone has been available to patients since 2012 following a conditional approval from the European Medicines Agency PARIS–(BUSINESS WIRE)–Servier today…